134 related articles for article (PubMed ID: 22409864)
1. Response of metastatic renal medullary carcinoma to carboplatinum and Paclitaxel chemotherapy.
Gangireddy Vg; Liles GB; Sostre GD; Coleman T
Clin Genitourin Cancer; 2012 Jun; 10(2):134-9. PubMed ID: 22409864
[No Abstract] [Full Text] [Related]
2. Metastatic apocrine carcinoma of the scalp: prolonged response to systemic chemotherapy.
Tlemcani K; Levine D; Smith RV; Brandwein-Gensler M; Staffenberg DA; Garg MK; Shifteh K; Haigentz M
J Clin Oncol; 2010 Aug; 28(24):e412-4. PubMed ID: 20406935
[No Abstract] [Full Text] [Related]
3. Prolonged survival of a patient with sickle cell trait and metastatic renal medullary carcinoma.
Pirich LM; Chou P; Walterhouse DO
J Pediatr Hematol Oncol; 1999; 21(1):67-9. PubMed ID: 10029817
[TBL] [Abstract][Full Text] [Related]
4. Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2.
Kosmidis PA; Syrigos K; Kalofonos HP; Dimopoulos MA; Skarlos D; Pavlidis N; Boukovinas I; Bafaloukos D; Pectasides D; Bacoyiannis C; Fountzilas G
Anticancer Res; 2012 Jan; 32(1):175-81. PubMed ID: 22213304
[TBL] [Abstract][Full Text] [Related]
5. Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy.
Lalisang RI; Erdkamp FL; Rodenburg CJ; Knibbeler-van Rossum CT; Nortier JW; van Bochove A; Slee PH; Voest EE; Wils JA; Wals J; Loosveld OJ; Smals AE; Blijham GH; Tjan-Heijnen VC; Schouten HC
Breast Cancer Res Treat; 2011 Jul; 128(2):437-45. PubMed ID: 21584666
[TBL] [Abstract][Full Text] [Related]
6. Renal medullary carcinoma: case report and review of the literature.
Noguera-Irizarry WG; Hibshoosh H; Papadopoulos KP
Am J Clin Oncol; 2003 Oct; 26(5):489-92. PubMed ID: 14528077
[TBL] [Abstract][Full Text] [Related]
7. [Metastasis of medullar thyroid carcinoma (case report)].
Moutaouakil A; Baha AT; Amraoui A
Bull Soc Belge Ophtalmol; 2003; (288):19-22. PubMed ID: 12879721
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of outcomes of Taxol + Cisplatin and Taxol + Nedaplatin chemotherapy regimens for advanced non-small cell lung cancer].
Cai YP; Xu S; Lin SJ
Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):74-5. PubMed ID: 20211076
[No Abstract] [Full Text] [Related]
9. Renal medullary carcinoma and sickle cell trait.
Friedrichs P; Lassen P; Canby E; Graham C
J Urol; 1997 Apr; 157(4):1349. PubMed ID: 9120938
[No Abstract] [Full Text] [Related]
10. Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma.
Walsh A; Kelly DR; Vaid YN; Hilliard LM; Friedman GK
Pediatr Blood Cancer; 2010 Dec; 55(6):1217-20. PubMed ID: 20979179
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL
Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156
[TBL] [Abstract][Full Text] [Related]
12. Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial.
Loibl S; Murmann C; Schwedler K; Warm M; Müller L; Heinrich G; Nekljudova V; von Minckwitz G
Cancer Chemother Pharmacol; 2009 Apr; 63(5):953-8. PubMed ID: 18716777
[TBL] [Abstract][Full Text] [Related]
13. Renal medullary carcinoma: an aggressive neoplasm in patients with sickle cell trait.
Pickhardt PJ
Abdom Imaging; 1998; 23(5):531-2. PubMed ID: 9841069
[TBL] [Abstract][Full Text] [Related]
14. Response to paclitaxel, gemcitabine, and cisplatin in renal medullary carcinoma.
Bell MD
Pediatr Blood Cancer; 2006 Aug; 47(2):228. PubMed ID: 16514612
[No Abstract] [Full Text] [Related]
15. Renal medullary carcinoma, a rare cause of haematuria in sickle cell trait.
Patel K; Livni N; Macdonald D
Br J Haematol; 2006 Jan; 132(1):1. PubMed ID: 16371012
[No Abstract] [Full Text] [Related]
16. Cystic presentation of a renal medullary carcinoma in a young woman.
Levi Sandri GB; Spoletini G; Lai Q; Mennini G; Rossi M
Urologia; 2015; 82(2):124-6. PubMed ID: 25451881
[TBL] [Abstract][Full Text] [Related]
17. Bone metastasis as the presenting complaint in ovarian carcinoma.
Kingston R; Sparkes J; Leen E; Stafford-Johnson D; Keogh P
Acta Obstet Gynecol Scand; 2001 Jul; 80(7):669-70. PubMed ID: 11437731
[No Abstract] [Full Text] [Related]
18. [Radiotherapy in treatment of relapsing renal cell cancer].
Metelev VV; Zharinov GM
Vopr Onkol; 2008; 54(6):775-7. PubMed ID: 19241859
[No Abstract] [Full Text] [Related]
19. Paclitaxel/carboplatin chemotherapy as primary treatment of brain metastases in non-small cell lung cancer: a preliminary report.
Lee JS; Pisters KM; Komaki R; Glisson BS; Khuri FR; Schea R; Fossella FV
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-52-S12-55. PubMed ID: 9331122
[TBL] [Abstract][Full Text] [Related]
20. [A case of progressive gastric carcinoma accompanied by disseminated carcinomatosis of bone marrow due to bone metastasis with DIC recovery by joint administration of 5-FU and paclitaxel].
Satoh D; Ninomiya M; Umeoka T; Harano M; Sasaki H; Aoki H; Onoda T; Shiozaki Y; Ohno S; Higaki K; Takakura N
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2079-81. PubMed ID: 17197758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
